Switch to
More onapp

How to use scorecard? Learn more

Nectar Lifesciences Ltd

NECLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹427 cr, stock is ranked 1,382
Moderate RiskStock is 2.75x as volatile as Nifty
19.450.40 (+2.10%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't faired well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹427 cr, stock is ranked 1,382
Moderate RiskStock is 2.75x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
17.05
PB RatioPB Ratio
0.39
Dividend YieldDiv. Yield
Sector PESector PE
33.93
Sector PBSector PB
4.15
Sector Div YldSctr Div Yld
0.93%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Nectar Lifesciences Limited is a pharmaceutical company. The Company's operations include manufacturing and marketing of oral and sterile cephalosporin's, phytochemicals and allied products.

Financial TrendFinancial statements 

20192020202120222.792.371.551.680.050.03-0.070.03
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 11.45%

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Updates 
Announced OnFeb 1, 2023

Nectar Lifesciences Limited has informed the Exchange regarding 'Dissolution of a Wholly Owned Subsidiary ( WOS ) of Nectar Lifesciences Limited ( Company ).'. | Download

Nectar Lifesciences Limited has informed the Exchange regarding 'Dissolution of a Wholly Owned Subsidiary ( WOS ) of Nectar Lifesciences Limited ( Company ).'. | Download

Updates 
Announced OnJan 3, 2023

Nectar Lifesciences Limited has informed the Exchange regarding 'Minutes/ Proceedings of the Ordinary/ Special Resolutions passed by way of Postal Ballot'. | Download

Nectar Lifesciences Limited has informed the Exchange regarding 'Minutes/ Proceedings of the Ordinary/ Special Resolutions passed by way of Postal Ballot'. | Download

Cash Dividend 
Ex. DateSep 11, 2020

Final • Div/Share: ₹ 0.05

See all events